Status:
NOT_YET_RECRUITING
Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients
Lead Sponsor:
The Institute of Molecular and Translational Medicine, Czech Republic
Conditions:
Acute Respiratory Failure
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
Mechanically ventilated intensive care patients will be sampled for a small amount of exhaled breath condensate from the ventilator circuit and for venous blood. Proteomic analysis of the exhaled bre...
Detailed Description
Exhaled breath condensate (EBC) is a product of gas exchange in the lungs. It contains plethora of substances of possible diagnostic value and its composition is likely to change rapidly in response t...
Eligibility Criteria
Inclusion
- Intensive care setting Mechanical ventilation Ventilator/ventilator circuit technically suitable for sampling of exhaled breath condensate
Exclusion
- Mechanical ventilation challenging to the extent that the insertion of the sampling kit into the ventilator circuit would substantially increase the risk for respiratory deterioration
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06189924
Start Date
January 1 2024
End Date
December 31 2029
Last Update
January 5 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Molecular and Translational Medicine, Palacky University
Olomouc, Czechia, 77900
2
University Hospital Olomouc
Olomouc, Czechia, 77900